Showing all 2 results
Amlodipine With Lisinopril Dehydrate Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated or Film Coated Tablets. The use of Lisinopril in its Dihydrate form ensures superior stability and predictable dissolution profiles.
Active Ingredient Strength (Standard) Therapeutic Role Amlodipine (as Besylate) BP/USP 5 mg / 10 mg Calcium Channel Blocker Lisinopril (as Dihydrate) BP/USP 5 mg / 10 mg / 20 mg ACE Inhibitor Excipients Q.S. Calcium Phosphate / Mannitol Stabilizing Agents Nifedipine Tablet
FreeProduct Composition & Structural Formats
We manufacture Nifedipine across the complete clinical dosage spectrum, utilizing distinct release matrices calibrated for immediate stabilization or sustained, once-daily therapeutic coverage.
Active Ingredient Available Strengths Formulation Matrix Delivery System Primary Clinical Focus Nifedipine IP/BP/USP 10 mg Immediate-Release / Rapid-Onset Film Tablet Acute Titration / Tocolysis: For severe acute hypertension or suppression of premature labor contractions. Nifedipine IP/BP/USP 20 mg Sustained-Release (SR) Retard Matrix Twice-Daily Maintenance: Intermediate control for stable chronic hypertension. Nifedipine IP/BP/USP 30 mg Once-Daily Extended-Release (XR / XL) Matrix First-Line Chronic Care: Continuous 24-hour plasma stabilization for mild-to-moderate hypertension. Nifedipine IP/BP/USP 60 mg Once-Daily Extended-Release (XR / XL) Matrix High-Potency Control: For refractory essential hypertension and severe chronic stable angina pectoris.



